The fatty liver index and risk of incident venous thromboembolism: the Tromsø Study.

For the relationship between obesity and venous thromboembolism (VTE), nonalcoholic fatty liver disease (recently termed metabolic dysfunction-associated steatotic liver disease) is of interest given the hepatic role in hemostasis.

Bibliographic Details
Published in:	Research and Practice in Thrombosis and Haemostasis
Main Authors:	Scheres, Luuk J J, Brækkan, Sigrid K, Verlaan, Judith P L, Cannegieter, Suzanne C, Hansen, John-Bjarne, Morelli, Vânia M
Format:	Article in Journal/Newspaper
Language:	English
Published:	PubMed Central 2024
Subjects:	epidemiology fatty liver obesity venous thromboembolism venous thrombosis Tromsø
Online Access:	https://doi.org/10.1016/j.rpth.2024.102447 https://pubmed.ncbi.nlm.nih.gov/38953053 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11215415/

Description
Summary:	For the relationship between obesity and venous thromboembolism (VTE), nonalcoholic fatty liver disease (recently termed metabolic dysfunction-associated steatotic liver disease) is of interest given the hepatic role in hemostasis.